ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 606869 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 606869; 2) Community: the network communities that were significantly associated with the response to NSC 606869; 3) Molecule: the relationships between components within communities and NSC 606869; 4) MDR: the compounds that were significantly associated with the NSC 606869.

NSC Compound Enrichment Correlation
NSC 728133 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-3,5-dichlorobenzene 0.0126882509540132 0.12353536
NSC 732737 Null 0.0126882509540132 0.18325303
NSC 733891 arypurine derivatives 0.0126882509540132 0.10136846
NSC 752270 2,7-Bis-[3-(2-chloro-benzylamino)-propyl]-benzo[lmn][3,8]phenanthroline-1,3,6,8-tetraone di-p-toluensulfonate 0.0126882509540132 0.081565649
NSC 759878 Irinotecan hydrochloride (USAN) 0.0126882509540132 0.49575466
NSC 99445 1-.beta.-D-Arabinofuranosylcytosine 5'-phosphate 0.0126882509540132 0.5275531
NSC 105014 Cladribine 0.0126882509540134 0.70671611
NSC 132313 Dianhydrogalactitol 0.0126882509540134 0.36850624
NSC 135687 5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) 0.0126882509540134 0.18011904
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0126882509540134 0.19050316
Total:66  Current:21    [First] [Prev] [Next] [Last]